Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-21-021003
Filing Date
2021-11-01
Accepted
2021-11-01 16:37:02
Documents
2
Period of Report
2021-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_163579900895956.html 3  
1 FORM 3 wf-form3_163579900895956.xml 3 1705
2 FISCHER POA ex24fischer.txt EX-24 3925
  Complete submission text file 0001628280-21-021003.txt   7216
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO CA 92121
Business Address
Fischer Seth H. Z. (Reporting) CIK: 0001573553 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35986 | Film No.: 211367763